This is a concise how-to of successfully treating previously poorly or untreatable neurologic conditions with stem cell therapies. The text examines the IRB approved protocols of NEST (Neurologic Bone Marrow Derived Stem Cell Treatment Study), SCiExVr (Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study), and ACIST (Alzheimer's and Cognitive Impairment Stem Cell Treatment Study). The discussion focuses on the protocols and informed consents and may be used as a template for specialists to develop clinical trials utilizing stem cell based therapy. Other potential noninvasive treatments for brain injury are also discussed.
Neurologic Stem Cell Surgery, the sister text to the recently published Retinal and Optic Nerve Stem Cell Surgery, is an invaluable reference for all physicians with an interest in the development of stem cell based treatments.
Auflage
Sprache
Verlagsort
Verlagsgruppe
Springer International Publishing
Zielgruppe
Illustrationen
4 farbige Tabellen, 4 farbige Abbildungen, 1 s/w Abbildung
4 Tables, color; 4 Illustrations, color; 1 Illustrations, black and white; X, 128 p. 5 illus., 4 illus. in color.
Maße
Höhe: 20.3 cm
Breite: 12.7 cm
ISBN-13
978-3-030-72419-1 (9783030724191)
DOI
10.1007/978-3-030-72420-7
Schweitzer Klassifikation
Jeffrey N. Weiss, MD
The Healing Institute
Margate, FL, USA
Jeffrey N. Weiss, MD is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at the Massachusetts Institute of Technology. He entered college at 16 years of age, and medical school at age 19 on full scholarships. While in medical school he obtained a degree in Electrical Engineering, Magna Cum Laude with distinction, and graduated from Medical School, Summa Cum Laude, at 23 years of age.
Dr. Weiss is the author of more than 100 publications, including 11 books, holds more than 20 U.S. and foreign patents, and has been a Reviewer for multiple scholarly journals. He has served as a Visiting Professor, performed surgery, and lectured nationally and internationally. Dr. Weiss is also the founder of two companies, Ocular Research Associates Inc., and Micron Ophthalmic, Inc. which have manufactured and sold Dr. Weiss' inventions worldwide.
Dr. Weiss performed the first retinal stem cell surgery in the world in 2010 and is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II, the largest retinal and optic nerve stem cell studies in the world, The Neurologic Stem Cell Treatment Study, The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study, and The Alzheimer's, Cognitive Impairment and Autism Treatment Study. The studies are Institutional Review Board (IRB) approved, registered with NIH and listed on ClinicalTrials.gov.
Dr. Weiss first visited Dubai in 2008, where equipment he had invented was being showcased at Arab Health, the second largest medical equipment meeting in the world. In 2015, he obtained a Dubai medical license and has been travelling to Dubai to examine patients, perform surgery and lecture. His work has been featured in all the major Dubai newspapers and television. He was a finalist for the United Arab Emirates HealthCare Award in 2018 and 2019.
Introduction
1. ClinicalTrials.gov listings - Study Protocols and Informed Consent2. Neurologic Bone Marrow Derived Stem Cell Treatment Study (NEST)3. Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study (SCiExVR) 4. Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study (ACIST) 5. Procedure - Additional Patient Explanation6. Some Thoughts7. Other Treatment Modalities
